Symposium Posters

The 2021 NETRF Virtual Research Symposium was held online on October 11-15, 2021. The meeting had over 300 attendees and included close to 60 presentations by NET researchers from around the world. Thirty-two posters were presented and grouped into the same four sessions based on NET type as were the oral presentations. Please note that some presenters chose not to post their presentations online following the meeting and have been respectfully omitted here.

  • Session 1. Gastrointestinal NETS
  • Session 2. Multiple NETs
  • Session 3. Pheochromocytoma and Paraganglioma
  • Session 4. Pancreatic NETs

Short videos of the author presenting their work may be viewed here and the abstracts and posters may be downloaded.  Please click on any of the posters you would like to see and use the filters to search for specific ones based on the session topic or the presenting author’s last name. If you wish to change search filters, reset it to ‘Select’ before switching.

To view Symposium talks, visit the Symposium Videos webpage by Clicking Here.

Search by Session or by Name

Select Session

XPO1 Inhibition Suppresses the Growth of Pancreatic Neuroendocrine Tumors

Presenter: Uddin

The Wnt signaling protein Dishevelled targets Somatostatin Receptor 2 for lysosomal degradation

Presenter: Carr

The physiologically relevant functions of the Daxx/Atrx/H3.3 axis

Presenter: Sun

The impact of SARS CoV2 pandemic on PRRT in neuroendocrine patients: one year experience in an ENETS certified center

Presenter: Grana

The Impact of Microbiome on Diagnostic and Therapeutic Theranostics in Gastroentero-pancreatic Neuroendocrine Tumors (GEP-NETs)

Presenter: Mohamed

Survival differences of lung neuroendocrine tumors in California by sociodemographic, clinicopathologic, and treatment factors

Presenter: Mulvey

Role of chromogranin A-derived fragments after resection of non-functioning pancreatic neuroendocrine tumors

Presenter: Andreasi

Representation of Racial Groups in Genomic Studies of Gastroenteropancreatic Neuroendocrine Neoplasms

Presenter: Herring

Peptide photosensitizer conjugates for implementation in GLP1R and SSTR targeted photodynamic therapy of neuroendocrine tumors

Presenter: Van Lith

PANDORA 2 protocol; intervention study to improve the quality of life in patients with small (≤2 cm) pancreatic neuroendocrine tumors

Presenter: Chen

mRNA expression of mTOR signaling components and MGMT promoter methylation status as potential predictive biomarkers in pancreatic neuroendocrine neoplasms

Presenter: Wolfshoefer

Molecular characterisation of pulmonary supra-carcinoids through integration of multi-omics data

Presenter: Sexton

Mesenteric fibrosis in small intestinal neuroendocrine tumors

Presenter: Hodgetts